# Multiple-Dose Study of VGX-1027 in Healthy Subjects

> **NCT00760396** · PHASE1 · COMPLETED · sponsor: **VGX Pharmaceuticals, LLC** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** VGX-1027

## Key facts

- **NCT ID:** NCT00760396
- **Lead sponsor:** VGX Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-11
- **Final completion:** 2009-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760396, "Multiple-Dose Study of VGX-1027 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00760396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*